Response to Comments: Chemotherapy Drugs and their Adjuncts (L37205)

This article is a response-to-comments summary regarding Draft Local Coverage Determination DL37205 (Chemotherapy Drugs and their Adjuncts) and does not itself establish clinical coverage criteria. No specific indications, limitations, documentation requirements, or frequency limits are stated in this article; refer to the underlying LCD DL37205 for substantive coverage rules and criteria.